{"id":108294,"date":"2021-05-25T07:24:28","date_gmt":"2021-05-25T07:24:28","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=108294"},"modified":"2021-05-25T07:24:28","modified_gmt":"2021-05-25T07:24:28","slug":"alpers-disease","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/alpers-disease\/","title":{"rendered":"Alpers disease"},"content":{"rendered":"

Alpers disease, also known as progressive infantile poliodystrophy, is a neurological condition occurring in infants and children. The degeneration of cerebral gray matter results in motor disturbances, seizures, and dementia. It is also common for patients with Alpers disease to develop liver damage. Although a familial form has been identified, the etiology is still unknown for most cases. Males and females are affected equally. There are very few cases of Alpers disease reported in the United States.<\/p>\n

\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Alpers disease, also known as progressive infantile poliodystrophy, is a neurological condition occurring in infants and children. The degeneration of cerebral gray matter results in motor disturbances, seizures, and dementia. It is also common for patients with Alpers disease to develop liver damage. Although a familial form has been identified, the etiology is still unknown […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-108294","post","type-post","status-publish","format-standard","hentry","category-a"],"yoast_head":"\nAlpers disease - Definition of Alpers disease<\/title>\n<meta name=\"description\" content=\"Alpers disease, also known as progressive infantile poliodystrophy, is a neurological condition occurring in infants and children. The degeneration of cerebral gray matter results in motor disturbances, seizures, and dementia. It is also common for patients with Alpers disease to develop liver damage. Although a familial form has been identified, the etiology is still unknown for most cases. Males and females are affected equally. There are very few cases of Alpers disease reported in the United States.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/alpers-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alpers disease - Definition of Alpers disease\" \/>\n<meta property=\"og:description\" content=\"Alpers disease, also known as progressive infantile poliodystrophy, is a neurological condition occurring in infants and children. The degeneration of cerebral gray matter results in motor disturbances, seizures, and dementia. It is also common for patients with Alpers disease to develop liver damage. Although a familial form has been identified, the etiology is still unknown for most cases. Males and females are affected equally. There are very few cases of Alpers disease reported in the United States.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/alpers-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-25T07:24:28+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/alpers-disease\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/alpers-disease\/\",\"name\":\"Alpers disease - Definition of Alpers disease\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-05-25T07:24:28+00:00\",\"dateModified\":\"2021-05-25T07:24:28+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Alpers disease, also known as progressive infantile poliodystrophy, is a neurological condition occurring in infants and children. The degeneration of cerebral gray matter results in motor disturbances, seizures, and dementia. It is also common for patients with Alpers disease to develop liver damage. Although a familial form has been identified, the etiology is still unknown for most cases. Males and females are affected equally. There are very few cases of Alpers disease reported in the United States.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/alpers-disease\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/alpers-disease\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/alpers-disease\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alpers disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alpers disease - Definition of Alpers disease","description":"Alpers disease, also known as progressive infantile poliodystrophy, is a neurological condition occurring in infants and children. The degeneration of cerebral gray matter results in motor disturbances, seizures, and dementia. It is also common for patients with Alpers disease to develop liver damage. Although a familial form has been identified, the etiology is still unknown for most cases. Males and females are affected equally. There are very few cases of Alpers disease reported in the United States.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/alpers-disease\/","og_locale":"en_US","og_type":"article","og_title":"Alpers disease - Definition of Alpers disease","og_description":"Alpers disease, also known as progressive infantile poliodystrophy, is a neurological condition occurring in infants and children. The degeneration of cerebral gray matter results in motor disturbances, seizures, and dementia. It is also common for patients with Alpers disease to develop liver damage. Although a familial form has been identified, the etiology is still unknown for most cases. Males and females are affected equally. There are very few cases of Alpers disease reported in the United States.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/alpers-disease\/","og_site_name":"Glossary","article_published_time":"2021-05-25T07:24:28+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/alpers-disease\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/alpers-disease\/","name":"Alpers disease - Definition of Alpers disease","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-05-25T07:24:28+00:00","dateModified":"2021-05-25T07:24:28+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Alpers disease, also known as progressive infantile poliodystrophy, is a neurological condition occurring in infants and children. The degeneration of cerebral gray matter results in motor disturbances, seizures, and dementia. It is also common for patients with Alpers disease to develop liver damage. Although a familial form has been identified, the etiology is still unknown for most cases. Males and females are affected equally. There are very few cases of Alpers disease reported in the United States.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/alpers-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/alpers-disease\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/alpers-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Alpers disease"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108294","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=108294"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108294\/revisions"}],"predecessor-version":[{"id":108295,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108294\/revisions\/108295"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=108294"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=108294"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=108294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}